Activity value 76italy Buyer&Supplier,Last transaction date:
2026-06-30
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for chiesi farmaceuticic s.p.a. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 219 transactions, with a transaction quantity of 2905228.03 and a transaction weight of 14765.97.
YearTransactionsQuantityWeight
20255397614573.7330994.82
20262192905228.0314765.97
Bill of lading data
<
1/15
>
Trade date
2026/06/30
B/L No.
2600002969
Suppliers
chiesi farmaceuticic s.p.a.
Buyers
oep philippines inc.
Product description
5,000 NR BECLOMETASONE DIPROPIONATE + FORMOTEROL FUMARATE DIHYDRATE (FOSTER NEXTHALER) 100MCG/6 MCG PER DOSE POWDER FOR INHALATION, BATCH NO. 1227566 (100MCG/6 MCG PER ACTUATION POWDER FOR INHALATION)
Expand
Product description
CUROSURF STERILE SUSPENSION IN VIALS FOR INTRATRACHEAL INSTILLATION GENETIC NAME IS PORACTANT ALFA QTY DECLARED IN NR. DUE TO UNIT VALUE IN NR. NET WEIGHT 22.5-KGS
Expand
Product description
CUROSURF STERILE SUSPENSION IN VIALS FOR INTRATRACHEAL INSTILLATION GENETIC NAME IS PORACTANT ALFA QTY DECLARED IN NR. DUE TO UNIT VALUE IN NR. NET WEIGHT 9-KGS
Expand
Product description
ATEM NEBULISER SOLUTION (IPRATROPIUM BROMIDE VIALS) MEDICINE QTY DECLARED IN NR. DUE TO UNIT VALUE IN NR. NET WEIGHT 2069.885-KGS
Expand
Hs code
30049099
Product tags
t 25,ipratropium bromide,nebuliser,sol,ty d,ion,vial,medicine,alu,unit,gh
Product description
ATEM NEBULISER SOLUTION (IPRATROPIUM BROMIDE VIALS) MEDICINE QTY DECLARED IN NR. DUE TO UNIT VALUE IN NR. NET WEIGHT 2583.451-KGS
Expand
Product description
ATEM NEBULISER SOLUTION (IPRATROPIUM BROMIDE VIALS) MEDICINE QTY DECLARED IN NR. DUE TO UNIT VALUE IN NR. NET WEIGHT 3112.187-KGS
Expand
Product description
CLENIL AEROSOL NEBULISING SUSPENSION (BECLOMETHASONE MONODOSE VIALS) QTY DECALRED IN NR. DUE TO UNIT VALUE IN NR. (NET WEIGHT) 3784.32-KGS.
Expand
Product description
(ACTIVE PHARMACEUTICALS INGREDIENTS API) PIROXICAM BETA-CYCLODEXTRIN CAS NO. 96684-40-1, Note: for CD 5th Schedule Part II of Table-A at Sr. No. 230, for ACD: 1151(I)/2025 Sr. No. 3(iii) Date: 30-06-2025, for RD: 1152/(I)/2025 Sr. No. 2(c) Date: 30-06-2025
Expand
Product description
(ACTIVE PHARMACEUTICALS INGREDIENTS API) PIROXICAM BETA-CYCLODEXTRIN CAS NO. 96684-40-1, Note: for CD 5th Schedule Part II of Table-A at Sr. No. 230, for ACD: 1151(I)/2025 Sr. No. 3(iii) Date: 30-06-2025, for RD: 1152/(I)/2025 Sr. No. 2(c) Date: 30-06-2025
Expand
Product description
(ACTIVE PHARMACEUTICALS INGREDIENTS API) PIROXICAM BETA-CYCLODEXTRIN CAS NO. 96684-40-1, Note: for CD 5th Schedule Part II of Table-A at Sr. No. 230, for ACD: 1151(I)/2025 Sr. No. 3(iii) Date: 30-06-2025, for RD: 1152/(I)/2025 Sr. No. 2(c) Date: 30-06-2025
Expand
Trade date
2026/06/24
B/L No.
tzda-26-1426710
Suppliers
chiesi farmaceuticic s.p.a.
Buyers
phillips pharmaceuticals tanzania ltd.
POLs
——
PODs
tzda
Supply area
Italy
Purchas area
Tanzania
Weight
63.6kg
Amount
13408.0524
Hs code
300490000000
Product tags
vial,pey,3m
Product description
PEYONA 3ml/60mg 10 VIALS INT
Expand
chiesi farmaceuticic s.p.a. is italy Buyer&Supplier,
and primarily engages in the import and export business of products such as gh,ty d,unit.
According to the 52wmb.com global trade database, as of 2026-06-30, the company has completed 4421 international trades,
with its main trading regions covering pakistan,colombia,russia etc.
The core products include HS30049099,HS30043900,HS3004902900 etc,
often transported via milano linate,port genoa, port amsterdam etc,
and its main trading partners are chiesi pharamaceuticals pvt ltd.,amarey nova medical s.a.,оао фармстандарт лексредства.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on chiesi farmaceuticic s.p.a. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.